BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18354037)

  • 1. BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.
    Morales AA; Gutman D; Lee KP; Boise LH
    Blood; 2008 May; 111(10):5152-62. PubMed ID: 18354037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic induction of apoptosis by p53-inducible Bcl-2 family proteins Noxa and Puma.
    Nakajima W; Tanaka N
    J Nippon Med Sch; 2007 Apr; 74(2):148-57. PubMed ID: 17507791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
    Matulis SM; Morales AA; Yehiayan L; Croutch C; Gutman D; Cai Y; Lee KP; Boise LH
    Mol Cancer Ther; 2009 May; 8(5):1197-206. PubMed ID: 19417148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells.
    Yuan Z; Wang F; Zhao Z; Zhao X; Qiu J; Nie C; Wei Y
    PLoS One; 2011; 6(5):e20586. PubMed ID: 21655183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines.
    Yu Q; Chen B; Zhang X; Qian W; Ye B; Zhou Y
    Planta Med; 2013 Jun; 79(9):775-81. PubMed ID: 23700110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
    Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S
    Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies.
    Chen S; Dai Y; Pei XY; Myers J; Wang L; Kramer LB; Garnett M; Schwartz DM; Su F; Simmons GL; Richey JD; Larsen DG; Dent P; Orlowski RZ; Grant S
    Cancer Res; 2012 Aug; 72(16):4225-37. PubMed ID: 22693249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma.
    Matulis SM; Morales AA; Yehiayan L; Lee KP; Cai Y; Boise LH
    PLoS One; 2012; 7(12):e52662. PubMed ID: 23285138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.
    Inoue S; Riley J; Gant TW; Dyer MJ; Cohen GM
    Leukemia; 2007 Aug; 21(8):1773-82. PubMed ID: 17525724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
    Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
    Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated cell death and lymphocyte homeostasis cause premature lethality in mice lacking the BH3-only proteins Bim and Bmf.
    Labi V; Woess C; Tuzlak S; Erlacher M; Bouillet P; Strasser A; Tzankov A; Villunger A
    Blood; 2014 Apr; 123(17):2652-62. PubMed ID: 24632712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo.
    Hübner A; Cavanagh-Kyros J; Rincon M; Flavell RA; Davis RJ
    Mol Cell Biol; 2010 Jan; 30(1):98-105. PubMed ID: 19841067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of arsenic trioxide on induction of apoptosis in MCL cell line and its possible mechanisms].
    Fei AM; Mao CM; Liu JJ; Zhu J; Mi JQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):909-13. PubMed ID: 20723298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.
    Cragg MS; Jansen ES; Cook M; Harris C; Strasser A; Scott CL
    J Clin Invest; 2008 Nov; 118(11):3651-9. PubMed ID: 18949058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex.
    Gomez-Bougie P; Oliver L; Le Gouill S; Bataille R; Amiot M
    Oncogene; 2005 Dec; 24(54):8076-9. PubMed ID: 16091744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737.
    Pétigny-Lechartier C; Duboc C; Jebahi A; Louis MH; Abeilard E; Denoyelle C; Gauduchon P; Poulain L; Villedieu M
    Mol Cancer Ther; 2017 Jan; 16(1):102-115. PubMed ID: 27980105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737.
    Hauck P; Chao BH; Litz J; Krystal GW
    Mol Cancer Ther; 2009 Apr; 8(4):883-92. PubMed ID: 19372561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.
    Lunghi P; Giuliani N; Mazzera L; Lombardi G; Ricca M; Corradi A; Cantoni AM; Salvatore L; Riccioni R; Costanzo A; Testa U; Levrero M; Rizzoli V; Bonati A
    Blood; 2008 Sep; 112(6):2450-62. PubMed ID: 18583568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
    Zhou XJ; Zhou YH; Chen XH; Qian WB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.